Nanjing Pharmaceutical Group Company Limited engages in the distribution of pharmaceuticals, medical devices, and health products in China. It also involved in the wholesale and retail of pharmaceuticals; provision of internet + Chinese medicine pharmacy service platform; and pharmaceutical third-party logistics services. The company was formerly known as NanJing Pharmaceutical Company Limited and change its name to Nanjing Pharmaceutical Group Company Limited in December 2025. Nanjing Pharmaceutical Group Company Limited was founded in 1951 and is based in Nanjing, China.
Research context
NanJing Pharmaceutical Company Limited appears in PyInvesting’s Shanghai Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- CNY
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
5 years, 6 months ago
NanJing Pharmaceutical Company Limited is currently in a long term uptrend where the price is trading 2.1% above its 200 day moving average.
From a valuation standpoint, the stock is 99.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.1.
NanJing Pharmaceutical Company Limited's total revenue rose by 13.5% to $11B since the same quarter in the previous year.
Its net income has increased by 78.3% to $94M since the same quarter in the previous year.
Finally, its free cash flow fell by 67.1% to $948M since the same quarter in the previous year.
Based on the above factors, NanJing Pharmaceutical Company Limited gets an overall score of 4/5.